U.S. markets open in 5 hours 26 minutes

Aziyo Biologics, Inc. (AZYO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.18-0.20 (-1.93%)
At close: 4:00PM EDT

Aziyo Biologics, Inc.

12510 Prosperity Drive
Suite 370
Silver Spring, MD 20904
United States
240 247 1147
http://www.aziyo.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees171

Key Executives

NameTitlePayExercisedYear Born
Mr. Ronald K. LloydCEO, Pres & Director890.57kN/A1961
Dr. Darryl Roberts Ph.D.Exec. VP of Operations & Product Devel.468.24kN/A1961
Dr. Jerome Riebman FACC, M.A., M.D.Chief Medical Officer552.69kN/A1954
Mr. Matthew B. FergusonChief Financial OfficerN/AN/A1968
Ms. Courtney GuyerVP of MarketingN/AN/AN/A
Mr. Thomas EngleseChief Commercial OfficerN/AN/A1974
Mr. Jeffry D. HametVP of Fin., Treasurer & Sec.N/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Corporate Governance

Aziyo Biologics, Inc.’s ISS Governance QualityScore as of June 1, 2021 is 10. The pillar scores are Audit: 5; Board: 10; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.